The controlling shareholder of Star Lake Bioscience (600866.SH) has completed the increase in holding of the company's 0.68% stake.
Star Lake Technology (600866.SH) has announced that its controlling shareholder, Guangdong Guangxin Holdings Group Co., Ltd. (abbreviated as...)
Star Lake Bioscience (600866.SH) announced that the controlling shareholder Guangdong Guangxin Holding Group Co., Ltd. (referred to as "Guangxin Group") has completed the implementation of its share increase plan. Guangxin Group has acquired a total of 11.3018 million shares of the company through centralized competitive bidding on the Shanghai Stock Exchange, representing 0.68% of the total share capital of the company. The total amount of the share increase is RMB 51.2965 million. This share increase plan has been completed.
Related Articles
Sinolink: The bottom of the real estate market may not be far away. It is expected to stabilize in the first and second quarters of next year.
Tencent (00700) first systematically disclosed R&D progress: AI generates 50% of new code, R&D automation level increases by 67% year-on-year.
China Securities Co., Ltd.: Investment Opportunities in the Commercial Aerospace Industry Chain
Sinolink: The bottom of the real estate market may not be far away. It is expected to stabilize in the first and second quarters of next year.
Tencent (00700) first systematically disclosed R&D progress: AI generates 50% of new code, R&D automation level increases by 67% year-on-year.
China Securities Co., Ltd.: Investment Opportunities in the Commercial Aerospace Industry Chain
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
